Monoclonal Antibodies in Cancer Treatment: A Review of Recent Progress

ISSN： 1173-8804

Source： BioDrugs, Vol.12, Iss.3, 1999-09, pp. : 209-236

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Monoclonal Antibodies Targeting Vascular Endothelial Growth Factor: Current Status and Future Challenges in Cancer Therapy

By Hsu Jerry Y. Wakelee Heather A.

BioDrugs, Vol. 23, Iss. 5, 2009-10 ,pp. : 289-304

Adis International

Access to resources Recommend Favorite

New Anti-CD20 Monoclonal Antibodies for the Treatment of B-Cell Lymphoid Malignancies

By Robak Tadeusz Robak Ewa

BioDrugs, Vol. 25, Iss. 1, 2011-02 ,pp. : 13-25

Adis International

Access to resources Recommend Favorite

Smarter Drugs: A Focus on Pan-Specific Monoclonal Antibodies

By Fagète Séverine Fischer Nicolas

BioDrugs, Vol. 25, Iss. 6, 2011-12 ,pp. : 357-364

Adis International

Access to resources Recommend Favorite

Trends in the Development and Approval of Monoclonal Antibodies for Viral Infections

By Reichert Janice M.

BioDrugs, Vol. 21, Iss. 1, 2007-01 ,pp. : 1-7

Adis International

Access to resources Recommend Favorite

Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies: Concepts and Lessons for Drug Development

By Mould Diane R. Green Bruce

BioDrugs, Vol. 24, Iss. 1, 2010-02 ,pp. : 23-39

Adis International

Access to resources Recommend Favorite